Postdoctoral Fellow: Tumor Immunology

Job Details: A full-time Postdoctoral position is immediately available from the laboratory of Dr. Jonathan Bromberg in the Center for Vascular and Inflammatory Diseases and Surgery department, at University of Maryland School of Medicine. The recently funded research project focuses on signaling pathways that control immune cell migration and cancer cell migration/metastasis, and their roles in cancer biology and therapy. The Dr. Jonathan Bromberg lab ( https://www.medschool.umaryland.edu/surgery/Research-/Research-Divisions/Transplant-Surgery-Research/Jonathan-Bromberg-MD-PhD/ ) utilizes cellular, genetic approaches and next-generation sequencing methods to discover key determinants of immune cell migration and function. The molecular focus of the project is directed to NFkB signal pathway regulated genes related to tumor progression and migration/metastases. Specific cellular elements include regulatory suppressive T cells, effector T cells, vascular and lymphatic endothelial cells, stromal cells, and dendritic cell subsets. Techniques include heavy reliance on in vivo animal models, migration and trafficking assays.

Successful candidates with recent PhD in biology or life sciences will have lab research training in cell and molecular biology. Experience with mice tumor model (e.g., melanoma, breast cancer) is a plus, but not required.

Expectations: Funding is available for three years. Motivated self-starter with the ability to participate creatively in collaborative teams across the laboratory is most welcome.

To apply: Please send letter of interest, your contact information, CV, and list of three references to: Dr. Jonathan S. Bromberg: jbromberg@som.umaryland.edu or Dr. Wenji Piao: wpiao@som.umaryland.edu

Recent Publications:

1. Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, Lape IT, Paluskievicz C, Hippen KL, Lee Y, Silverman E, Shirkey MW, Riella LV, Blazar BR, Bromberg JS. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nature Comm. 2022 Apr 21;13(1):2176. DOI: 10.1038/s41467-022-29930-0.
2. Xiong Y, Piao W, Brinkman CC, Li L, Kulinski JM, Olivera A, Cartier A, Hla T, Hippen K, Blazar B, Schwab SR, Bromberg JS. Sphingosine 1-phosphate (S1P) receptors differentially regulate CD4 T cell migration across afferent lymphatic endothelium. Science Immunology 2019,4(33): eaav1263. DOI: 10.1126/sciimmunol.aav1263
3. Piao W, Xiong Y, Li L, Saxena V, Smith KD, Hippen KL, Paluskievicz C, Willsonshirkey M, Blazar BR, Abdi R, Bromberg JS. Regulatory T Cells Condition Lymphatic Endothelia for Enhanced Transendothelial Migration. Cell Rep. 2020 Jan 28;30(4):1052-1062.e5. DOI: 10.1016/j.celrep.2019.12.083.
4. Piao W, Xiong Y, Famulski K, Brinkman CC, Li L, Wagner C, Saxena V, Simon T, Bromberg JS. Regulation of T cell afferent lymphatic migration by targeting LTbR-mediated non-classical NFB signaling. Nature Comm. 2018, 9:3020. DOI: 10.1038/s41467-018-05412-0

Jonathan S. Bromberg, MD, PhD

Charles Reid Edwards, MD Professor of Surgery

Professor of Microbiology and Immunology

Vice Chair for Research

University of Maryland School of Medicine

22 S. Greene St., S8B11

Baltimore, MD 21201

Office 410-328-0008

Cell 917-968-4428

FAX 410-328-0401

jbromberg@som.umaryland.edu

Qualifications :

Successful candidates with recent PhD in biology or life sciences will have lab research training in cell and molecular biology. Experience with mice tumor model (e.g., melanoma, breast cancer) is a plus, but not required.